Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study
W. Eiermann(Ludwig-Maximilians-Universität München), Semiglazov Vf(Institute of Oncology NN Petrov), L. Mauriac(Institut Bergonié), Antonio Llombart‐Cussac(MedSIR (Spain)), Justus Appfelstaedt(Stellenbosch University), M. Borgs(Novartis (Switzerland)), Stefan Paepke(Charité - Universitätsmedizin Berlin), Matthew J. Ellis(Guardant (United States)), M. Lassus(Unknown), Hilary A. Chaudri‐Ross(Novartis (Switzerland)), J. Eremin(St George's Hospital), J. Vinholes(Santa Casa Hospital), Margaret Dugan(Universität Hamburg)
Cited by 714
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
|Journal of Clinical Oncology|2017|1.7k
The molecular portraits of breast tumors are conserved across microarray platforms
|BMC Genomics|2006|1.5k